Latest News

Journal Articles

Brain and neurologic

Zika vaccine yields promising results for treating glioblastoma

Has the secret of the immortality cancer switch been unlocked?

Estimated lifetime survival benefit of tumor treating fields and temozolomide for newly diagnosed glioblastoma patients


Vistusertib with paclitaxel shows promise for ovarian and lung cancer in early trial

Tamoxifen, SERMs and sustainable medicine: an interview with V. Craig Jordan & Balkees Abderrahman

3D printed life-sized breast cancer tumors created


Data-driven blood test could be a step towards personalized treatment for bowel cancer

Chemicals found in vegetables prevent colon cancer in mice

Colorectal cancer screening age to be lowered to 50 in England


Blood test could detect kidney cancer up to 5 years earlier

Exploring the Thyroid Imaging Reporting and Data System (TI-RADS): an interview with Franklin Tessler

FDA approves first-in-class treatment for rare adrenal tumors


A remarkable insight into the cancer journey of Barbara Moss

Conference Chair highlights: World Congress on Gastrointestinal Cancer

ESMO WCGI: Trifluridine and tipiracil show promise as metastatic gastric cancer treatment in Phase III trial


NICE approves atezolizumab for advanced bladder cancer patients on the NHS

Breakthrough method to diagnose prostate cancer developed

Researchers uncover 80 potential ways of targeting prostate cancer


Vistusertib with paclitaxel shows promise for ovarian and lung cancer in early trial

Targeting BRAF mutations to treat ovarian cancer

Ovarian cancer progression delayed by Lynparza® treatment

Head and neck

Diabetics face a higher risk of mouth cancer, with women more at risk

The importance of a multidisciplinary team in the care of head and neck cancer

The importance of sentinel lymph node biopsies in the diagnosis of head and neck cancer


Kymriah® is set to become the first CAR-T therapy available on the NHS

CAR T therapy Yescarta get EU green light but meets resistance from NICE

Increased risk of myeloid blood cancers in relatives of patients


Reasoning the effect of immunotherapy after chemoradiation in the PACIFIC trial

Lung squamous cell carcinoma: key molecular player discovered

Chinese regulators approve Alecensa® for NSCLC, hot on heels of FDA and EMA approvals


ESMO WCGI: Study highlights first-line treatment variations for pancreatic cancer

ESMO WCGI: Adjuvant FOLFIRINOX new standard of care for pancreatic cancer

ASCO18: Preoperative chemoradiotherapy improves survival time for patients with pancreatic cancer


Circulating tumor cells: researchers develop mechanism for characterizing function

Immunotherapy may be an effective therapy for prostate cancer with mismatch repair mutations

Hair loss gene could be exploited to improve cancer immunotherapy

Rare tumors

Osteoblastoma genetic marker shows promise for identifying aggressive tumors

Best of ASCO18: key takeaways & the practice-changing talks

Practice-changing breakthrough made for rare cancer


NICE approves dabrafenib–trametinib for BRAF+ melanoma

Hair loss gene could be exploited to improve cancer immunotherapy

New FDA oncology drug approvals and indications